Back to HomeBeta

ICD-10 Coding for Acute Myelogenous Leukemia(C92.00, C92.01)

Complete ICD-10-CM coding and documentation guide for Acute Myelogenous Leukemia. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Acute Myeloid LeukemiaAML

Related ICD-10 Code Ranges

Complete code families applicable to Acute Myelogenous Leukemia

C92.0-C92.9Primary Range

Acute myeloblastic leukemia

This range includes all subtypes of acute myelogenous leukemia, which is the primary focus for coding this condition.

Myelodysplastic syndromes

Relevant for coding AML secondary to MDS, which requires sequencing with MDS codes.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C92.00Acute myeloblastic leukemia not having achieved remissionUse when AML is newly diagnosed and not in remission.
  • Bone marrow biopsy showing ≥20% blasts
  • CD117+/MPO+ staining
C92.01Acute myeloblastic leukemia, in remissionUse when AML is in complete remission as per clinical criteria.
  • Documented remission criteria: <5% blasts, ANC >1,000/μL

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for acute myelogenous leukemia

Essential facts and insights about Acute Myelogenous Leukemia

The ICD-10 code for AML not in remission is C92.00, and C92.01 for AML in remission.

Primary ICD-10-CM Codes for acute myelogenous leukemia

Acute myeloblastic leukemia not having achieved remission
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed diagnosis with ≥20% blasts

Applicable To

  • AML not in remission

Excludes

  • Chronic myeloid leukemia (C92.1-)

Clinical Validation Requirements

  • Bone marrow biopsy showing ≥20% blasts
  • CD117+/MPO+ staining

Code-Specific Risks

  • Ensure documentation supports lack of remission status to avoid audits.

Coding Notes

  • Ensure remission status is clearly documented.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of leukemia

Z85.6
Use to document history of leukemia when applicable.

Encounter for antineoplastic chemotherapy

Z51.11
Use to document ongoing chemotherapy treatment.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Acute lymphoblastic leukemia

C91.0-
Differentiated by lymphoid lineage markers such as CD19+.

Acute myeloblastic leukemia, in relapse

C92.02
Use when there is a documented increase in blast percentage indicating relapse.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Acute Myelogenous Leukemia to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C92.00.

Impact

Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential for incorrect billing and reimbursement.

Mitigation Strategy

Regularly review and update patient records, Ensure clinical criteria are documented

Impact

Reimbursement: Unspecified codes may lead to lower reimbursement rates., Compliance: Increases risk of audit due to lack of specificity., Data Quality: Reduces the accuracy of clinical data for research and treatment planning.

Mitigation Strategy

Always specify the subtype and remission status of AML.

Impact

Inadequate documentation of remission status can trigger audits.

Mitigation Strategy

Ensure all remission criteria are clearly documented in patient records.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Acute Myelogenous Leukemia, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Acute Myelogenous Leukemia

Use these documentation templates to ensure complete and accurate documentation for Acute Myelogenous Leukemia. These templates include all required elements for proper coding and billing.

AML Diagnosis and Treatment

Specialty: Oncology

Required Elements

  • Diagnosis confirmation
  • Remission status
  • Treatment plan

Examples: Poor vs. Good Documentation

Poor Documentation Example
AML diagnosed, treatment ongoing.
Good Documentation Example
AML diagnosed with 25% blasts, CD117+; induction therapy initiated.
Explanation
The good example provides specific diagnostic and treatment details.

Need help with ICD-10 coding for Acute Myelogenous Leukemia? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more